Summary of Product Characteristics
last updated on the eMC:
16/03/2010
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 16/03/2010 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 4.3 - Contraindications
|
| Date of revision of text on the SPC: 08-Mar-2010 |
| Legal Category: P |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
Sectin 4.3 - Now includes the following text
Hypersensitivity to calcium glubionate, calcium lactobionate or to any of the excipients.
|
|
Updated on 21/12/2004 and displayed until 16/03/2010
|
Reasons for adding or updating:
|
-
Transferred from eMC version 1
|
|
Updated on 21/12/2004 and displayed until 21/12/2004
|
Reasons for adding or updating:
|
-
Transferred from eMC version 1
|
|
Updated on 21/12/2004 and displayed until 21/12/2004
|
Reasons for adding or updating:
|
-
Transferred from eMC version 1
|
|
Updated on 21/12/2004 and displayed until 21/12/2004
|
Reasons for adding or updating:
|
-
Improved Electronic Presentation
|
|
Updated on 16/01/2003 and displayed until 21/12/2004
|
Reasons for adding or updating:
|
-
Transferred from eMC version 1
|
|
Updated on 16/07/2001 and displayed until 16/01/2003
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
|
|
Updated on 12/07/2001 and displayed until 16/07/2001
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
|
|
Updated on 06/09/1999 and displayed until 12/07/2001
|
Reasons for adding or updating:
|
|
|
|
